A hiatal hernia occurs when part of the stomach pushes upward through the diaphragm. The opening in the diaphragm is called the hiatus. Normally, the oesophagus passes through this opening to reach the stomach. Doctors classify hiatal hernias into four main types. Type I is the most common form. In this type, the stomach and […]
Category: Medicine
Pulmonary Pathology of Respiratory Viral Infections: Influenza, RSV, and SARS-CoV-2 Respiratory viruses commonly target the lungs. Influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 cause significant pulmonary disease. Each virus produces distinct yet overlapping patterns of lung injury. Understanding these pathological changes helps explain clinical severity. Influenza primarily infects the airway epithelium. The virus damages ciliated […]
Seroprevalence and Risk Factors of Scrub Typhus, Leptospirosis, and Brucellosis in Fever Cases and Healthy Populations in Northeastern and Central India Researchers examine three important zoonotic diseases across northeastern and central India. They focus on scrub typhus, leptospirosis, and brucellosis. These infections often present as fever of unknown origin. Studies target both acute fever cases […]
Mesothelioma remains difficult to detect at an early stage. Doctors therefore explore blood and fluid-based biomarkers. Three proteins receive special attention. These are mesothelin, fibulin-3 and osteopontin. Each offers useful information for diagnosis and monitoring. Mesothelin appears in high amounts on mesothelioma cell surfaces. The body releases a soluble form into the blood. This form […]
Liquid biopsy analyzes body fluids for cancer-related markers. Researchers apply this method to track mesothelioma progression. The approach avoids repeated invasive tissue biopsies. Therefore, it offers a safer option for patients. Mesothelioma often develops in the lining of the lungs or abdomen. Traditional monitoring relies on imaging and tissue samples. However, these methods have limitations. […]
Sonrotoclax (Beqalzi) Approved as New Treatment for Relapsed Mantle Cell Lymphoma Sonrotoclax is a next-generation BCL2 inhibitor. BeOne Medicines developed it. The drug carries the brand name Beqalzi. The FDA granted it accelerated approval in May 2026. Doctors can now use it for relapsed or refractory mantle cell lymphoma. Patients must have already received at […]